Janux Therapeutics (JANX) Financials: Revenue & Earnings

JANX price $17.46 +0.20 +1.16%

Ticker
JANX
Price
$17.46
Change
+0.20 +1.16%
Market cap ?
$1.07B
P/E ?
-10.10
Dividend yield ?
0.00%
Beta ?
2.39
Sector
Healthcare
Industry
Biotechnology
Stocklytics score
63
Value
59
Quality
30
Growth
100

Stocklytics score rationale: value 59, quality 30, growth 100.

Financials

2019202020212022202320242025
003637000861200080830001058800010000000

Janux Therapeutics, Inc. is a biopharmaceutical company dedicated to developing innovative cancer therapies. The firm leverages its proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to create treatments designed to activate the body's T cells to fight tumors. Currently, Janux has several promising TRACTr product candidates in their early preclinical or discovery stages, which are engineered to…

Fair value

JANX fair value Not meaningful. Price $17.46.

Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.

Not meaningful

Compare JANX

Earnings

DateEPS actualEPS estimateRevenueRevenue estimate
2026-11-05—-0.47—8.03M
2026-08-06-0.35-0.2510.27M19.07M
2026-05-07-0.39-0.523.73M4.36M
2026-02-26-0.51-0.657.88M83.33K
2025-11-06-0.39-0.6010.00M—
2025-08-07-0.55-0.48—300.00K
2025-05-08-0.38-0.43—660.00K
2025-02-27-0.36-0.49—1.82M
2024-11-06-0.51-0.37439.00K1.50M
2024-08-07-0.11-0.328.90M1.45M
2024-05-07-0.30-0.351.25M660.00K
2024-03-08-0.25-0.372.46M740.00K
2023-11-07-0.25-0.462.52M590.00K
2023-08-08-0.42-0.521.06M875.00K
2023-05-09-0.42-0.492.05M870.00K
2023-03-10-0.39-0.452.85M670.00K
2022-11-10-0.40-0.511.81M790.00K
2022-08-09-0.41-0.372.37M650.00K
2022-05-10-0.32-0.371.59M810.40K
2022-03-18-0.33-0.301.62M433.33K
2021-11-09-0.26-0.171.16M130.00K
2021-08-10-0.62-0.13482.00K482.00K
2021-06-11-0.13———
2021-03-31-0.06—380.00K—
2020-09-30-0.10———
2020-06-30-0.20———
2020-03-31-0.11———

Dividends

Yield 0.00%. Payout ratio 0.00%. Frequency —.

Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.

Ex-dateDividendRecordPaymentFrequency
No data yet.

Insider trades

DateInsiderActionSharesPriceValue
2026-07-31Campbell David AlanSell123.84K——
2026-07-08Campbell David AlanSell7.00K$4.2129.47K
2026-07-08Campbell David AlanBuy7.00K$4.2129.47K
2026-06-11RA CAPITAL MANAGEMENT, L.P.Buy15.50K$13.66211.73K
2026-06-11RA CAPITAL MANAGEMENT, L.P.Buy5.50K——
2026-06-11Simson JakeBuy15.50K$13.66211.73K
2026-06-11Simson JakeBuy5.50K——
2026-06-11Kung WinstonBuy15.50K$13.66211.73K
2026-06-11Kung WinstonBuy5.50K——
2026-06-11Hernday NatashaBuy15.50K$13.66211.73K
2026-06-11Hernday NatashaBuy5.50K——
2026-06-11DOBMEIER ERICBuy15.50K$13.66211.73K
2026-06-11DOBMEIER ERICBuy5.50K——
2026-06-11CAPPS VICKIE LBuy5.50K——
2026-06-11CAPPS VICKIE LBuy15.50K$13.66211.73K
2026-06-11Barrett Ronald WBuy15.50K$13.66211.73K
2026-06-11Barrett Ronald WBuy5.50K——
2026-06-02Doyle Janeen NoelSell4.06K$14.0356.94K
2026-05-11Dobek MariaSell2.04K$14.1728.88K
2026-02-02Go WilliamBuy154.00K$13.992.15M
2026-02-02Go WilliamBuy44.00K——
2026-01-26Go WilliamOther0——
2026-01-02Meyer Andrew HollmanSell1.88K$13.7325.80K
2026-01-02DiRaimondo ThomasBuy31.40K——
2026-01-02DiRaimondo ThomasSell2.50K$13.7334.39K
2026-01-02DiRaimondo ThomasBuy109.90K$13.651.50M
2026-01-02Campbell David AlanBuy96.60K——
2026-01-02Campbell David AlanBuy338.10K$13.654.62M
2026-01-02Campbell David AlanSell8.07K$13.73110.83K
2026-01-02Winter Charles M.Buy28.60K——
2026-01-02Winter Charles M.Buy100.10K$13.651.37M
2026-01-02Winter Charles M.Sell2.40K$13.7332.97K
2026-01-02McIver ZachariahBuy101.50K$13.651.39M
2026-01-02McIver ZachariahBuy29.00K——
2026-01-02McIver ZachariahSell2.71K$13.7337.26K
2026-01-02Doyle Janeen NoelBuy126.00K$13.651.72M
2026-01-02Doyle Janeen NoelBuy36.00K——
2026-01-02Dobek MariaBuy42.60K$13.65581.49K
2026-01-02Dobek MariaBuy18.93K——
2026-01-02Dobek MariaSell1.46K$13.7320.07K
2025-12-01Meyer Andrew HollmanSell3.33K$10.5935.30K
2025-12-01Meyer Andrew HollmanBuy3.33K$10.5935.30K
2025-12-01Meyer Andrew HollmanSell2.70K$32.8588.71K
2025-12-01Meyer Andrew HollmanSell633$33.5221.22K
2025-11-14Meyer Andrew HollmanSell3.33K$10.5935.30K
2025-11-14Meyer Andrew HollmanBuy3.33K$10.5935.30K
2025-11-14Meyer Andrew HollmanSell3.33K$30.0099.99K
2025-10-28Meyer Andrew HollmanSell6.67K$10.5970.59K
2025-10-28Meyer Andrew HollmanBuy6.67K$10.5970.59K
2025-10-28Meyer Andrew HollmanBuy10.00K$4.2142.10K
2025-10-28Meyer Andrew HollmanSell16.66K$30.06500.99K
2025-10-28Meyer Andrew HollmanSell10.00K$4.2142.10K
2025-06-11RA CAPITAL MANAGEMENT, L.P.Buy11.67K$25.46297.04K
2025-06-11RA CAPITAL MANAGEMENT, L.P.Buy3.75K——
2025-06-11Barrett Ronald WBuy11.67K$25.46297.04K
2025-06-11Barrett Ronald WBuy3.75K——
2025-06-11CAPPS VICKIE LBuy3.75K——
2025-06-11CAPPS VICKIE LBuy11.67K$25.46297.04K
2025-06-11DOBMEIER ERICBuy11.67K$25.46297.04K
2025-06-11DOBMEIER ERICBuy3.75K——
2025-06-11Gujrathi SheilaBuy3.75K——
2025-06-11Gujrathi SheilaBuy11.67K$25.46297.04K
2025-06-11Hernday NatashaBuy11.67K$25.46297.04K
2025-06-11Hernday NatashaBuy3.75K——
2025-06-11McNulty Alana B.Buy11.67K$25.46297.04K
2025-06-11McNulty Alana B.Buy3.75K——
2025-06-11Simson JakeBuy11.67K$25.46297.04K
2025-06-11Simson JakeBuy3.75K——
2025-06-11Kung WinstonBuy11.67K$25.46297.04K
2025-06-11Kung WinstonBuy3.75K——
2025-06-02Doyle Janeen NoelBuy154.00K$25.013.85M
2025-06-02Doyle Janeen NoelBuy44.00K——
2025-05-14Doyle Janeen NoelOther0——
2025-05-01Meyer Andrew HollmanSell3.33K$4.2114.03K
2025-05-01Meyer Andrew HollmanBuy3.33K$4.2114.03K
2025-05-01Meyer Andrew HollmanSell2.93K$31.9593.70K
2025-05-01Meyer Andrew HollmanSell400$32.6013.04K
2025-04-21Meyer Andrew HollmanSell3.33K$4.2114.04K
2025-04-21Meyer Andrew HollmanBuy3.33K$4.2114.04K
2025-04-21Meyer Andrew HollmanSell3.33K$30.00100.02K
2025-03-07RA CAPITAL MANAGEMENT, L.P.Buy110.21K$31.023.42M
2025-03-06RA CAPITAL MANAGEMENT, L.P.Buy372.09K$30.7811.45M
2025-03-05RA CAPITAL MANAGEMENT, L.P.Buy37.45K$31.301.17M
2025-03-05RA CAPITAL MANAGEMENT, L.P.Buy304.29K$30.569.30M
2025-03-03Meyer Andrew HollmanSell3.33K$4.2114.04K
2025-03-03Meyer Andrew HollmanBuy3.33K$4.2114.04K
2025-03-03Meyer Andrew HollmanSell2.43K$31.8877.58K
2025-03-03Meyer Andrew HollmanSell901$32.8529.60K
2025-02-03Meyer Andrew HollmanSell3.33K$4.2114.04K
2025-02-03Meyer Andrew HollmanBuy3.33K$4.2114.04K
2025-02-03Meyer Andrew HollmanSell2.42K$42.08101.74K
2025-02-03Meyer Andrew HollmanSell816$42.7734.90K
2025-02-03Meyer Andrew HollmanSell100$43.604.36K
2025-01-07Campbell David AlanSell5.00K$60.00300.00K
2025-01-02McIver ZachariahBuy91.00K$53.244.84M
2025-01-02McIver ZachariahBuy26.00K——
2025-01-02Winter Charles M.Buy80.50K$53.244.29M
2025-01-02Winter Charles M.Buy23.00K——
2025-01-02Campbell David AlanBuy81.00K——
2025-01-02Campbell David AlanBuy283.50K$53.2415.09M

Institutional holders

Latest filed quarter: Q2 2026.

Institutions holding: 205, holders +5 vs prior quarter. Ownership 97.17%.

HolderSharesChangeChange %Value
RA CAPITAL MANAGEMENT, L.P.11.19M00.00%171.87M
BLACKROCK, INC.6.13M701.43K+12.91%94.23M
PROSIGHT MANAGEMENT, LP3.80M254.48K+7.17%58.44M
STATE STREET CORP3.00M540.88K+21.95%46.16M
FMR LLC2.41M-122.90K-4.85%37.06M
FEDERATED HERMES, INC.2.35M2.30M+4241.19%36.14M
POINT72 ASSET MANAGEMENT, L.P.1.99M837.70K+72.46%30.63M
VANGUARD CAPITAL MANAGEMENT LLC1.86M45.99K+2.54%28.53M
TCG CROSSOVER MANAGEMENT, LLC1.79M00.00%27.49M
ALYESKA INVESTMENT GROUP, L.P.1.65M46.05K+2.88%25.30M
WELLINGTON MANAGEMENT GROUP LLP1.51M-90.29K-5.65%23.15M
VANGUARD PORTFOLIO MANAGEMENT LLC1.33M40.45K+3.14%20.44M
TWO SIGMA INVESTMENTS, LP1.21M1.09M+939.85%18.54M
GEODE CAPITAL MANAGEMENT, LLC1.20M57.43K+5.01%18.50M
CITADEL ADVISORS LLC1.20M1.16M+2660.31%18.44M
ALGERT GLOBAL LLC1.11M667.49K+150.54%17.06M
D. E. SHAW & CO., INC.1.10M998.11K+1014.40%16.84M
GOLDMAN SACHS GROUP INC952.67K350.66K+58.25%14.63M
BANK OF AMERICA CORP /DE/910.46K108.81K+13.57%13.98M
MORGAN STANLEY836.97K133.03K+18.90%12.86M
NANTAHALA CAPITAL MANAGEMENT, LLC809.91K00.00%12.44M
QUBE RESEARCH & TECHNOLOGIES LTD702.06K504.91K+256.11%10.78M
SQUAREPOINT OPS LLC532.32K-71.68K-11.87%8.18M
ORBIMED ADVISORS LLC524.70K-458.90K-46.66%8.06M
MILLENNIUM MANAGEMENT LLC504.54K117.73K+30.44%7.75M

Earnings and financials

Janux Therapeutics, Inc. (JANX) trades at $17.46, with a market cap of $1.07B and a trailing P/E of -10.10. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.

Financials

2019202020212022202320242025
003637000861200080830001058800010000000

Insights · Dividends · Forecast · Financials · Learn

Stocklytics home · Screener

Janux Therapeutics (JANX) Financials: Revenue & Earnings

JANX$17.46+0.20 +1.16%

$1.07B

Market Cap

-10.10

P/E

—

Forward P/E

63

Score

Price History